The Value of Orencia in Rapidly Progressing Rheumatoid Arthritis: A Chart Review Study
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 28 Jun 2018
Price : $35 *
At a glance
- Drugs Abatacept (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Bristol-Myers Squibb
- 31 Aug 2018 Biomarkers information updated
- 19 Jun 2018 Planned End Date changed from 30 Jun 2018 to 30 Jan 2019.
- 19 Jun 2018 Planned primary completion date changed from 30 Apr 2018 to 30 Jan 2019.